Astera Labs, Inc. $ALAB Shares Purchased by Harbour Investments Inc.

Harbour Investments Inc. increased its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 207.7% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,446 shares of the company’s stock after purchasing an additional 1,651 shares during the quarter. Harbour Investments Inc.’s holdings in Astera Labs were worth $221,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Oliver Lagore Vanvalin Investment Group acquired a new position in Astera Labs during the second quarter worth $29,000. Bernard Wealth Management Corp. acquired a new position in Astera Labs during the second quarter worth $36,000. Ameritas Advisory Services LLC acquired a new position in Astera Labs during the second quarter worth $64,000. GAMMA Investing LLC raised its holdings in Astera Labs by 55.7% during the first quarter. GAMMA Investing LLC now owns 794 shares of the company’s stock worth $47,000 after purchasing an additional 284 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. acquired a new position in Astera Labs during the first quarter worth $48,000. 60.47% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Astera Labs

In related news, CFO Michael Truett Tate sold 100,000 shares of the company’s stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $171.38, for a total value of $17,138,000.00. Following the completion of the transaction, the chief financial officer directly owned 518,996 shares in the company, valued at approximately $88,945,534.48. This represents a 16.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Stefan A. Dyckerhoff sold 25,000 shares of the company’s stock in a transaction on Thursday, August 7th. The shares were sold at an average price of $173.42, for a total value of $4,335,500.00. Following the completion of the transaction, the director owned 99,154 shares of the company’s stock, valued at $17,195,286.68. The trade was a 20.14% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 1,092,997 shares of company stock valued at $192,231,120. Corporate insiders own 12.50% of the company’s stock.

Astera Labs Trading Up 0.8%

Astera Labs stock opened at $157.51 on Wednesday. The firm has a market capitalization of $26.18 billion, a P/E ratio of 281.27, a PEG ratio of 3.89 and a beta of 1.43. The stock has a fifty day moving average price of $198.53 and a 200 day moving average price of $129.72. Astera Labs, Inc. has a 52 week low of $47.13 and a 52 week high of $262.90.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.33 by $0.11. The firm had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The business’s quarterly revenue was up 149.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.13 earnings per share. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, equities analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on ALAB. Wall Street Zen raised Astera Labs from a “hold” rating to a “buy” rating in a report on Saturday. Cowen began coverage on Astera Labs in a report on Tuesday, September 30th. They issued a “hold” rating for the company. Evercore ISI boosted their price target on Astera Labs from $104.00 to $215.00 and gave the stock an “outperform” rating in a report on Wednesday, August 6th. Deutsche Bank Aktiengesellschaft boosted their price target on Astera Labs from $160.00 to $200.00 and gave the stock a “buy” rating in a report on Tuesday, September 2nd. Finally, Susquehanna boosted their price target on Astera Labs from $80.00 to $125.00 and gave the stock a “neutral” rating in a report on Thursday, August 7th. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Astera Labs has an average rating of “Moderate Buy” and a consensus target price of $162.06.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.